Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

MORE INFORMATION

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

MORE INFORMATION

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

MORE INFORMATION

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

LINKEDIN PAGE

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

READ NOW

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

READ NOW

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

WATCH THE VIDEO

Welcome To IRDiRC

Our vision: Enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention

Goal 1

All patients coming to medical attention with a suspected rare disease will be diagnosed within one year if their disorder is known in the medical literature; all currently undiagnosable individuals will enter a globally coordinated diagnostic and research pipeline

Goal 2

1000 new therapies for rare diseases will be approved, the majority of which will focus on diseases without approved options

Goal 3

Methodologies will be developed to assess the impact of diagnoses and therapies on rare disease patients

Watch Our Presentation Video

Latest News

Rare Disease Day 2024: What IRDiRC member organizations are up to?

February 29, 2024

Join us in spreading awareness this Rare Disease Day.The International Rare Diseases Research…

Fondazione Telethon announces commitment to make gene therapy for Wiskott-Aldrich Syndrome available to patients

February 28, 2024

Today, 28th of February, Fondazione Telethon (Italy) launched a Press Release to announce…

IRDiRC at 2024 WODC USA

February 26, 2024

As part of our commitment in advancing initiatives related to rare diseases, IRDiRC…